Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

les laboratoires servier industrie - metoprolol (metoprolol tartrate), ivabradine (ivabradine hydrochloride) - tablets film-coated - 50mg+ 7,5mg

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - ivabradine adipate - film coated tablet - 5 milligram - other cardiac preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - ivabradine adipate - film coated tablet - 7.5 milligram - other cardiac preparations

Malta - English - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - ivabradine adipate - film-coated tablet - ivabradine adipate 5 mg - cardiac therapy

Malta - English - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - ivabradine adipate - film-coated tablet - ivabradine adipate 7.5 mg - cardiac therapy

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.